跳至主要内容
临床试验/NCT02379169
NCT02379169Unknown不适用

Effects of Sea Buckthorn Oil and Lutein on Eye Health

Turku University Hospital0 个研究点目标入组 90 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
90
主要终点
Change in macular pigment optical density from baseline to 6 mo

研究概览

简要总结

Low macular pigment optical density has been associated with increased risk of age-related macular degeneration, an important cause of vision problems in the elderly population. Dry eye is multifactorial disease of tears and the ocular surface associated with symptoms of dryness, grittiness, burning and redness of eyes. The risk of dry eye increases with age. The aim is to investigate the effects of sea buckthorn oil complemented with lutein on eye health, specifically on the macula.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • macular pigment optical density equal to or less than 0,40 OD

排除标准

  • diabetic retinopathy
  • macular changes associated with high blood pressure
  • signs of macular degeneration: classes 2, 3 and 4 according to the Rotterdam study (Mol Vis 2012: 657-74)
  • severe eye diseases, exluding cataract. The intervention will begina after surgery and recovery from cataract

结局指标

主要结局

Change in macular pigment optical density from baseline to 6 mo

时间窗: 0 mo, 3 mo, 6 mo

measurement of macular pigment optical density

次要结局

  • Change in serum lipids (Triglycerides, HDL-cholesterol, LDL-cholesterol, total cholesterol) from baseline to 6 mo(0 months, 6 months)
  • Change in symptoms of dry eye from baseline to 6 mo(0 months, 3 months, 6 months)
  • Change in serum markers of inflammation (hs-CRP) from baseline to 6 mo(0 months, 6 months)
  • Change in circulating aminotransferases (ALAT, ASAT) from baseline to 6 mo(0 months, 6 months)
  • Change in contrast sensitivity from baseline to 6 mo(0 mo, 3 mo, 6 mo)
  • Change in vision aquity from baseline to 6 mo(0 mo, 3 mo, 6 mo)
  • Change in vision functioning from baseline to 6 mo(0 mo, 3 mo, 6 mo)
  • Change in tear film osmolarity from baseline to 6 mo(0 mo, 3 mo, 6 mo)

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验